Author: Scott Welch
New technologies are making it easier for companies to fix prices and discriminate against individual consumers, the Biden administration’s top consumer watchdog said Tuesday. Algorithms make it possible for companies to fix prices without explicitly coordinating with one another, posing a new test for regulators policing the market, said Lina Khan, chair of the Federal ...
Walgreens (WBA) is standing up a new specialty pharmacy segment to compete in an increasingly crowded pharmacy benefits manager (PBM) and specialty pharmacy space.
Tens of thousands of Medicaid recipients in Nevada will be without health insurance now that the pandemic-era continuous coverage policy for the program has ended.
In California, more than 2,100 bills were introduced for consideration by lawmakers in the second year of our 2023-2024 legislative session. For a bill to become law, it must pass through both the state Senate and Assembly, typically requiring a majority vote.
A large and diverse coalition of 150 California business representatives have joined a CalChamber-led coalition in strong opposition to AB 2200 (Kalra; D-San Jose), a job killer bill, that would create an expensive government bureaucracy to finance a state-run health care system.
At the House Energy and Commerce’s data privacy hearing April 17, lawmakers discussed for the first time Chair Cathy McMorris Rodgers’ discussion draft of a new federal data privacy bill, the American Privacy Rights Act (APRA), since its reveal last week.
Thursday, the Federal Trade Commission (FTC), the Department of Justice (DOJ) and the Department of Health and Human Services (HHS) unveiled HealthyCompetition.gov, an online portal where anyone can submit a healthcare competition complaint for potential investigation.
Mergers and acquisitions involving hospitals and other health care providers are drawing attention from federal and state regulators, including the Federal Trade Commission, and policymakers amid concerns that such consolidations can reduce competition and contribute to the high costs of health care. A new KFF brief examines and summarizes the evidence about consolidation among health care providers ...
Novo Nordisk's list price for a monthly package of Ozempic is $935.77 before insurance and other rebates, yet it can be manufactured for between $0.89 to $4.73 a month, according to researchers at Yale University.
A settlement between the drugmaker and insulin patients that would have capped patients' out-of-pocket insulin costs at $35 for 4 years has fallen apart, after an "unfavorable ruling" from the judge overseeing the case.